Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Mucin 1
100%
Triple Negative Breast Cancer
100%
Malignant Neoplasm
13%
Disease
13%
Immunotherapy
13%
Side Effect
6%
Clinical Trial
6%
Progesterone
6%
Solid Malignant Neoplasm
6%
Disease Exacerbation
6%
Tumor Antigen
6%
Survival Rate
6%
Infection
6%
Mouse Model
6%
Recurrent Disease
6%
Keyphrases
Mucin 1 (MUC1)
50%
Triple-negative Breast Cancer
50%
Adoptive Cell Therapy
50%
Tumor-specific
50%
Triple-negative Breast Cancer Cells
16%
Human Triple Negative Breast Cancer
13%
Engineered T Cells
13%
Treatment Refractory
13%
T Cells
10%
Antibody Fragment
6%
Clinical Collaboration
6%
Toxicity Issues
6%
Toxic Environment
6%
Cancer Antigen
6%
Blood Cancer
6%
Recurrence Rate
6%
Chemorefractory Disease
6%
Metastatic Triple-negative Breast Cancer
6%
Targeted Therapy
6%
Tumor
6%
Immunology and Microbiology
MUC1
100%
Cancer Cell
16%
T Cell
13%
Monospecific Antibody
6%
Immunotherapy
6%